Chemistry
How Molecular Docking Predicts Ligand-Binding Affinity at Receptor Sites
Quick fact
Molecular docking can virtually screen thousands of candidate drug molecules against a protein target in a single day, long before any chemical is synthesized or tested in a lab.
Why this is interesting
You've probably seen a key fitting into a lock, but what if both the key and the lock are shaped by thousands of weak molecular forces? How do scientists predict which drug will bind best—without touching a single test tube?
Read the full explanation
Understanding How Molecular Docking Predicts Ligand-Binding Affinity at Receptor Sites
At its heart, molecular docking is like finding the right key for a lock. The lock is your receptor—a protein with a specific pocket where molecules bind. The key is your ligand—a small molecule like a drug. The computer shakes the key around in the lock (poses) and scores how well each orientation fits (scoring function). The better the fit, the higher the score, which should correlate with how tightly the ligand binds. This score is interpreted as the binding affinity. The process has two main steps: searching possible poses and evaluating each one. The search algorithm explores different translation, rotation, and sometimes internal conformations of the ligand. The scoring function approximates the free energy of binding by summing terms for van der Waals forces, electrostatics, hydrogen bonds, and solvation effects. The final list of ranked poses gives researchers a prediction of which ligands are likely to bind well.
A deeper explanation
The mechanism behind docking relies on the lock-and-key model, but with a twist: both molecules are flexible in reality. Docking simulations often treat the receptor as rigid to save computation, while allowing the ligand to explore many conformations. The scoring function estimates the change in free energy (ΔG) upon binding. A more negative ΔG indicates stronger binding. Scoring functions are approximations; they often neglect entropy and solvation effects, so they are useful for ranking compounds rather than predicting exact affinities. More sophisticated methods, like MM-PBSA or thermodynamic integration, provide higher accuracy but require much more computation. Understanding these trade-offs is crucial for interpreting docking results in drug discovery pipelines.